Company Info
Phone(408) 777-1417
Year Established
1998
Ticker
DRRX
Exchange
NASDAQ
Contacts
Keith LuiVP, Business Development
James E. Brown, DMV
President & CEO
Timothy M. Papp
CFO
Norman L. Sussman, M.D., FAASLD
CMO
WeiQi Lin, M.D., Ph.D.
Executive VP, R&D
Steve Helmer
Chief Patent Counsel
Company Description
DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program.